Systems Genetics of Hepatic Metabolome Reveals Octopamine as a Target for Non-Alcoholic Fatty Liver Disease Treatment.
Brial F, Le Lay A, Hedjazi L, Tsang T, Fearnside JF, Otto GW, Alzaid F, Wilder SP, Venteclef N, Cazier JB, Nicholson JK, Day C, Burt AD, Gut IG, Lathrop M, Dumas ME, Gauguier D.
Brial F, et al. Among authors: tsang t.
Sci Rep. 2019 Mar 6;9(1):3656. doi: 10.1038/s41598-019-40153-0.
Sci Rep. 2019.
PMID: 30842494
Free PMC article.